In September 2025, Electronic Arts (EA) announced that it has agreed to the $55 billion acquisition deal proposed by Saudi Arabia’s Public Investment Fund (PIF),…
As demand for computing power reshapes the artificial intelligence landscape, Oracle is expanding its cloud infrastructure with hardware that was once outside its core business. …
Belenos Biosciences is a clinical-stage biotech developing immunotherapies for chronic inflammatory diseases, including asthma, chronic obstructive pulmonary disease, and atopic dermatitis. Founded in 2024, the…
Averna Therapeutics is a Boston‑based biotechnology company developing genomic medicines that insert therapeutic genetic material into defined locations within the human genome. Targeted insertion at…
In November 2025, Pfizer finalized its $10 billion acquisition of Metsera, a transaction that highlighted the company’s strategic push into the rapidly expanding obesity treatment…
Laekna Therapeutics is a clinical-stage biotech specializing in oncology and immunology, with a pipeline focused on drug-resistant cancers and combination-therapy strategies. Founded in 2016 and…
On September 23, 2025, South Korea–based biotechnology company Noul received U.S. FDA registration for its cervical cancer diagnostic cartridge system, miLab™ Cartridge CER, and its…
Helicore Biopharma has emerged as a notable player in obesity therapeutics research through its work on neutralizing the glucose-dependent insulinotropic polypeptide, or GIP. The company…
ARS Pharmaceuticals launched neffy in November 2025, introducing the first nasal treatment for anaphylaxis approved by the FDA. The product delivers a single dose of…
The latest 2025 USPTO patent data reveals a stable yet highly concentrated innovation landscape, where a small group of global technology leaders continues to dominate…
